Immunetrics' Solution:

Immunetrics powerful technology shifts clinical testing from trial and error to a confirmation of results. The advanced human biological modeling allows the testing of millions of virtual patients and thousands of treatment arms before affecting a single patient. This information has the potential to save years and millions of dollars in clinical testing.

For compounds entering Phase II, one of the greatest challenges lies in choosing which serum marker, among hundreds, will indicate probable biological activity of a therapeutic compound. The Immunetrics' model includes an extensive array of these markers that can be used to confirm what to test for and at what time.

For compounds entering Phase III trials, the extensive modeling and testing of virtual patients significantly impacts the trial efficacy through:

• Identification of patients most likely to respond favorably to the compound.
• Determination of optimal dosage, timing and duration of administration of a compound.
• Evaluation of compound effectiveness in combination with other drugs.

© 2007 Immunetrics